Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant to Augment Exposure Therapy in Veterans With PTSD and Insomnia
NCT07686731Phase 4Not yet recruiting
- Sponsor
- NCIRE - The Veterans Health Research Institute
- Start
- Sep 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in post-traumatic stress disorder (PTSD), Insomnia, sponsored by NCIRE - The Veterans Health Research Institute. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
suvorexant
03
Conditions
post-traumatic stress disorder (PTSD)Insomnia
Beyond the preview
Go deeper on NCT07686731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07686731.